Literature DB >> 32168421

Binding and Release of FeIII Complexes from Glucan Particles for the Delivery of T1 MRI Contrast Agents.

Akanksha Patel1, Didar Asik1, Eric M Snyder1, Alexandra E Dilillo1, Paul J Cullen2, Janet R Morrow1.   

Abstract

Yeast-derived β-glucan particles (GPs) are a class of microcarriers under development for the delivery of drugs and imaging agents to immune-system cells for theranostic approaches. However, the encapsulation of hydrophilic imaging agents in the porous GPs is challenging. Here, we show that the unique coordination chemistry of FeIII -based macrocyclic T1 MRI contrast agents permits facile encapsulation in GPs. Remarkably, GPs labeled with the simple FeIII complexes are stable under physiologically relevant conditions, despite the absence of amphiphilic groups. In contrast to the free FeIII coordination complex, the labeled FeIII -GPs have lowered T1 relaxivity and act as a silenced form of the contrast agent. Addition of a fluorescent tag to the FeIII complex produces a bimodal agent to further enable tracking of the nanoparticles and to monitor release. Treatment of the iron-labeled GPs with a maltol chelator or with mildly acidic conditions releases the intact iron complex and restores enhanced T1 relaxation of the water protons.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  acid-mediated release; beta-glucan microparticles; biocompatible delivery; chelator-mediated release; imaging agents; targeted delivery

Mesh:

Substances:

Year:  2020        PMID: 32168421     DOI: 10.1002/cmdc.202000003

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  5 in total

1.  Comparison of phosphonate, hydroxypropyl and carboxylate pendants in Fe(III) macrocyclic complexes as MRI contrast agents.

Authors:  Elizabeth A Kras; Samira M Abozeid; Waldine Eduardo; Joseph A Spernyak; Janet R Morrow
Journal:  J Inorg Biochem       Date:  2021-08-28       Impact factor: 4.336

2.  Liposomal Fe(III) Macrocyclic Complexes with Hydroxypropyl Pendants as MRI Probes.

Authors:  Samira M Abozeid; Md Saiful I Chowdhury; Didar Asik; Joseph A Spernyak; Janet R Morrow
Journal:  ACS Appl Bio Mater       Date:  2021-10-15

Review 3.  Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents.

Authors:  Shangjun Chen; Lu An; Shiping Yang
Journal:  Molecules       Date:  2022-07-18       Impact factor: 4.927

Review 4.  Iron-Based Hollow Nanoplatforms for Cancer Imaging and Theranostics.

Authors:  Shun Luo; Shuijie Qin; Gerile Oudeng; Li Zhang
Journal:  Nanomaterials (Basel)       Date:  2022-08-31       Impact factor: 5.719

5.  Modulating the Properties of Fe(III) Macrocyclic MRI Contrast Agents by Appending Sulfonate or Hydroxyl Groups.

Authors:  Didar Asik; Rachel Smolinski; Samira M Abozeid; Travis B Mitchell; Steven G Turowski; Joseph A Spernyak; Janet R Morrow
Journal:  Molecules       Date:  2020-05-13       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.